Anna Moore is the Director of MSU’s Precision Health Program and Assistant Dean at the College of Human Medicine. Her research is aimed at developing theranostic agents for imaging and therapy in cancer and diabetes.
Dr. Moore received her undergraduate degree in chemistry from Moscow State University and her Ph.D. in Bioorganic Chemistry from A.N. Bach Institute of Biochemistry, Academy of Sciences in Moscow, Russia. Moore previously worked at Massachusetts General Hospital and Harvard Medical School. She is the founder of TransCode Therapeutics and a member of the World Molecular Imaging Society and the International Society for Magnetic Resonance in Medicine.
Director, Precision Health Program Assistant Dean, College of Human Medicine Professor, Departments of Radiology and Physiology email@example.com
Development of image-guided nucleic-acid based therapies for cancer
Discovery of novel targets for eradication of cancer stem cells
Development of new universal multi-modal imaging agents for organ targeting and cell labeling
Development of imaging methods for early detection of endometriosis
1983 A.N. Belozersky Institute Annual Award (Best Diploma Award), Moscow State University, Moscow, Russia
1993 Memorial Award, American Association of University Radiologists
1999 Seed Grant Award, Radiological Society of North America (RSNA)
2000 Fellowship Research Training Prize “Near infrared fluorescent (NIRF) optical imaging as prognostic tool in human breast cancer animal model study”, RSNA
2002 Junior Faculty Award, American Diabetes Association
2003 Travel award to attend 63d ADA Scientific Sessions, American Diabetes Association
2008 Outstanding Teacher Award, International Society for Magnetic Resonance in Medicine
2014 Distinguished Investigator Award, Academy of Radiology Research